- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 41/10 - Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
Patent holdings for IPC class A61K 41/10
Total number of patents in this class: 85
10-year publication summary
|
4
|
5
|
5
|
12
|
11
|
6
|
11
|
15
|
10
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Biostem Technologies, Inc. | 65 |
5 |
| Prolong Pharmaceuticals, LLC | 17 |
4 |
| Terumo BCT Biotechnologies, LLC | 38 |
4 |
| Baxter International Inc. | 1895 |
3 |
| Baxter Healthcare S.A. | 1396 |
3 |
| Abbvie Inc. | 1838 |
3 |
| The Board of Trustees of the Leland Stanford Junior University | 6633 |
2 |
| Rmw CHO Group Limited | 20 |
2 |
| Sami Labs Limited | 105 |
2 |
| Sun Pharmaceutical Industries Limited | 723 |
2 |
| Ascendis Pharma A/S | 194 |
2 |
| Venner Shipley LLP | 15 |
2 |
| Anteris AUS Operations Pty Ltd | 10 |
2 |
| Shaanxi Baici Kangda Medical Technology Co., Ltd. | 3 |
2 |
| The Regents of the University of California | 20669 |
1 |
| Janssen Pharmaceutica N.V. | 3178 |
1 |
| The Regents of the University of Michigan | 4962 |
1 |
| Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung e.V. | 5224 |
1 |
| Aarhus Universitet | 445 |
1 |
| Advanced BioAdjuvants, LLC | 4 |
1 |
| Other owners | 41 |